

(Sharecast News) - Specialty biopharmaceutical company Circassia Pharmaceuticals updated the market on its licensing agreement with BeyondAir, previou...


Circassia Pharmaceuticals Notes Terminated Agreement With BeyondAir


LONDON MARKET OPEN: Listless Start To Trade; BoE To Keep Rates Steady


LONDON MARKET PRE-OPEN: Higher Call; Endeavour-Centamin Tussle Ongoing


Circassia Pharmaceuticals CEO Retires; Reiterates 2019 Guidance


Oryx International Builds 8% Holding In Circassia Pharmaceuticals


DIRECTOR DEALINGS: Circassia Pharma Chief Operating Officer Buys Stock


Circassia Pharmaceuticals Loss Widens On Revenue Fall, Costs, Expenses